the british institute for the study of iraq (gertrude bell memorial)

Live EstablishedMicroDeclining

the british institute for the study of iraq (gertrude bell memorial) Company Information

Share THE BRITISH INSTITUTE FOR THE STUDY OF IRAQ (GERTRUDE BELL MEMORIAL)

Company Number

06966984

Shareholders

-

Group Structure

View All

Industry

Activities of other membership organisations n.e.c.

 +1

Registered Address

10 carlton house terrace, london, SW1Y 5AH

the british institute for the study of iraq (gertrude bell memorial) Estimated Valuation

£132.4k

Pomanda estimates the enterprise value of THE BRITISH INSTITUTE FOR THE STUDY OF IRAQ (GERTRUDE BELL MEMORIAL) at £132.4k based on a Turnover of £164.4k and 0.81x industry multiple (adjusted for size and gross margin).

the british institute for the study of iraq (gertrude bell memorial) Estimated Valuation

£22.6k

Pomanda estimates the enterprise value of THE BRITISH INSTITUTE FOR THE STUDY OF IRAQ (GERTRUDE BELL MEMORIAL) at £22.6k based on an EBITDA of £4.5k and a 5.04x industry multiple (adjusted for size and gross margin).

the british institute for the study of iraq (gertrude bell memorial) Estimated Valuation

£6.1m

Pomanda estimates the enterprise value of THE BRITISH INSTITUTE FOR THE STUDY OF IRAQ (GERTRUDE BELL MEMORIAL) at £6.1m based on Net Assets of £2.5m and 2.42x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

The British Institute For The Study Of Iraq (gertrude Bell Memorial) Overview

The British Institute For The Study Of Iraq (gertrude Bell Memorial) is a live company located in london, SW1Y 5AH with a Companies House number of 06966984. It operates in the other education n.e.c. sector, SIC Code 85590. Founded in July 2009, it's largest shareholder is unknown. The British Institute For The Study Of Iraq (gertrude Bell Memorial) is a established, micro sized company, Pomanda has estimated its turnover at £164.4k with declining growth in recent years.

View Sample
View Sample
View Sample

The British Institute For The Study Of Iraq (gertrude Bell Memorial) Health Check

Pomanda's financial health check has awarded The British Institute For The Study Of Iraq (Gertrude Bell Memorial) a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 6 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating3.5out of 5
positive_score

3 Strong

positive_score

2 Regular

positive_score

6 Weak

size

Size

annual sales of £164.4k, make it smaller than the average company (£445.3k)

£164.4k - The British Institute For The Study Of Iraq (gertrude Bell Memorial)

£445.3k - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 0%, show it is growing at a slower rate (7.4%)

0% - The British Institute For The Study Of Iraq (gertrude Bell Memorial)

7.4% - Industry AVG

production

Production

with a gross margin of 72.4%, this company has a comparable cost of product (72.4%)

72.4% - The British Institute For The Study Of Iraq (gertrude Bell Memorial)

72.4% - Industry AVG

profitability

Profitability

an operating margin of 2% make it less profitable than the average company (3.2%)

2% - The British Institute For The Study Of Iraq (gertrude Bell Memorial)

3.2% - Industry AVG

employees

Employees

with 1 employees, this is below the industry average (11)

1 - The British Institute For The Study Of Iraq (gertrude Bell Memorial)

11 - Industry AVG

paystructure

Pay Structure

on an average salary of £42.4k, the company has a higher pay structure (£27.7k)

£42.4k - The British Institute For The Study Of Iraq (gertrude Bell Memorial)

£27.7k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £164.4k, this is more efficient (£51.4k)

£164.4k - The British Institute For The Study Of Iraq (gertrude Bell Memorial)

£51.4k - Industry AVG

debtordays

Debtor Days

There is insufficient data available for this Key Performance Indicator!

- - The British Institute For The Study Of Iraq (gertrude Bell Memorial)

- - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 54 days, this is slower than average (26 days)

54 days - The British Institute For The Study Of Iraq (gertrude Bell Memorial)

26 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 110 days, this is more than average (13 days)

110 days - The British Institute For The Study Of Iraq (gertrude Bell Memorial)

13 days - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 142 weeks, this is average cash available to meet short term requirements (143 weeks)

142 weeks - The British Institute For The Study Of Iraq (gertrude Bell Memorial)

143 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 1.4%, this is a lower level of debt than the average (19.9%)

1.4% - The British Institute For The Study Of Iraq (gertrude Bell Memorial)

19.9% - Industry AVG

THE BRITISH INSTITUTE FOR THE STUDY OF IRAQ (GERTRUDE BELL MEMORIAL) financials

EXPORTms excel logo

The British Institute For The Study Of Iraq (Gertrude Bell Memorial)'s latest turnover from March 2024 is £164.4 thousand and the company has net assets of £2.5 million. According to their latest financial statements, The British Institute For The Study Of Iraq (Gertrude Bell Memorial) has 1 employee and maintains cash reserves of £96.3 thousand as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Mar 2024Mar 2023Mar 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017Jun 2016Jun 2015Jun 2014Jun 2013Jun 2012Jun 2011Jun 2010
Turnover164,371174,59392,876164,95979,452134,838126,335108,48184,76090,478106,10299,24497,1514,020,923
Other Income Or Grants
Cost Of Sales45,30746,98023,30039,78819,04433,68832,70527,05637,61042,79854,31649,91649,0942,017,658
Gross Profit119,064127,61369,576125,17160,408101,15093,63081,42547,15047,68051,78649,32848,0572,003,265
Admin Expenses115,716237,41894,91446,839146,140144,084113,738130,042113,15592,330133,74588,698111,998-1,338,793
Operating Profit3,348-109,805-25,33878,332-85,732-42,934-20,108-48,617-66,005-44,650-81,959-39,370-63,9413,342,058
Interest Payable
Interest Receivable
Pre-Tax Profit6,284-105,706-24,53263,532-85,632-42,004-19,434-48,225-65,088-44,148-81,757-39,076-63,8162,473,123
Tax
Profit After Tax6,284-105,706-24,53263,532-85,632-42,004-19,434-48,225-65,088-44,148-81,757-39,076-63,8162,473,123
Dividends Paid
Retained Profit6,284-105,706-24,53263,532-85,632-42,004-19,434-48,225-65,088-44,148-81,757-39,076-63,8162,473,123
Employee Costs42,43041,03729,15936,85936,18345,10030,11326,38822,90522,13527,19540,40741,60529,140
Number Of Employees111111111112282
EBITDA*4,475-109,237-24,97778,813-85,732-42,934-20,107-48,149-65,537-44,182-81,807-39,142-63,4993,342,407

* Earnings Before Interest, Tax, Depreciation and Amortisation

Mar 2024Mar 2023Mar 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017Jun 2016Jun 2015Jun 2014Jun 2013Jun 2012Jun 2011Jun 2010
Tangible Assets2,0073,1341,326,5601,326,9211,327,4021,326,0001,326,0011,326,4691,326,9371,326,0001,326,1521,326,380822
Intangible Assets1,326,000
Investments & Other2,424,4902,459,6491,235,2701,209,8341,174,8182,559,4501,230,7371,243,2111,167,7651,176,9461,357,2501,336,6811,326,8231,379,580
Debtors (Due After 1 year)
Total Fixed Assets2,426,4972,462,7832,561,8302,536,7552,502,2202,559,4502,556,7372,569,2122,494,2342,503,8832,683,2502,662,8332,653,2032,706,402
Stock & work in progress13,69513,71413,73621,32621,45623,54727,67328,35629,44130,46134,47841,55830,88934,383
Trade Debtors1,300682176
Group Debtors
Misc Debtors16,45111,7992,2762,1682,0322,2541,8503,2071,88515,97717,61719,85514,76422,178
Cash96,26095,39397,499117,32587,049112,741135,335134,151179,558187,28013,44167,48049,980
misc current assets101,212
total current assets126,406120,906113,511142,119111,219138,543164,934165,714210,884233,71865,536128,89395,633157,773
total assets2,552,9032,583,6892,675,3412,678,8742,613,4392,697,9932,721,6712,734,9262,705,1182,737,6012,748,7862,791,7262,748,8362,864,175
Bank overdraft
Bank loan
Trade Creditors 6,7239,7035,7351,6176,4891,3421,2778,8115,0652,2842,67319,0407,100
Group/Directors Accounts
other short term finances
hp & lease commitments
other current liabilities28,33824,54214,81823,32626,88425,01429,95612,31215,2824,5326,7657,15017,4729,138
total current liabilities35,06134,24520,55324,94333,37326,35631,23321,12320,3476,8169,43826,19017,47216,238
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
total long term liabilities37,88637,52412,13512,39311,797
total liabilities35,06172,13158,07737,07845,76638,15331,23321,12320,3476,8169,43826,19017,47216,238
net assets2,517,8422,511,5582,617,2642,641,7962,567,6732,659,8402,690,4382,713,8032,684,7712,730,7852,739,3482,765,5362,731,3642,847,937
total shareholders funds2,517,8422,511,5582,617,2642,641,7962,567,6732,659,8402,690,4382,713,8032,684,7712,730,7852,739,3482,765,5362,731,3642,847,937
Mar 2024Mar 2023Mar 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017Jun 2016Jun 2015Jun 2014Jun 2013Jun 2012Jun 2011Jun 2010
Operating Activities
Operating Profit3,348-109,805-25,33878,332-85,732-42,934-20,108-48,617-66,005-44,650-81,959-39,370-63,9413,342,058
Depreciation1,1275683614811468468468152228442349
Amortisation
Tax
Stock-19-22-7,590-130-2,091-4,126-683-1,085-1,020-4,017-7,08010,669-3,49434,383
Debtors4,6529,523-1,192754459329-1,2811,322-14,092-1,640-2,2385,091-7,41422,178
Creditors-2,9803,9684,118-4,8725,14765-7,5343,7462,781-389-16,36719,040-7,1007,100
Accruals and Deferred Income3,7969,724-8,508-3,5581,870-4,94217,644-2,97010,750-2,233-385-10,3228,3349,138
Deferred Taxes & Provisions
Cash flow from operations658-105,046-20,58569,759-77,083-44,014-8,033-47,610-36,894-41,147-89,241-46,184-51,3573,302,084
Investing Activities
capital expenditure1,322,858-1,327,4021,326,000-1,405-1,327,171
Change in Investments-35,1591,224,37925,43635,016-1,384,6321,328,713-12,47475,446-9,181-180,30420,5699,858-52,7571,379,580
cash flow from investments35,15998,479-25,436-35,01657,230-2,71312,474-75,4469,181178,899-20,569-9,85852,757-2,706,751
Financing Activities
Bank loans
Group/Directors Accounts
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue10,591-6,53511,406-3,93177,25719,07435,58555,56973,248-52,757374,814
interest
cash flow from financing10,591-6,53511,406-3,93177,25719,07435,58555,56973,248-52,757374,814
cash and cash equivalents
cash867-2,106-19,82630,276-25,692-22,5941,184-45,407-7,722173,839-54,03917,50049,980
overdraft
change in cash867-2,106-19,82630,276-25,692-22,5941,184-45,407-7,722173,839-54,03917,50049,980

the british institute for the study of iraq (gertrude bell memorial) Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for the british institute for the study of iraq (gertrude bell memorial). Get real-time insights into the british institute for the study of iraq (gertrude bell memorial)'s credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

The British Institute For The Study Of Iraq (gertrude Bell Memorial) Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for the british institute for the study of iraq (gertrude bell memorial) by selecting its closest rivals, whether from the EDUCATION sector, other micro companies, companies in SW1Y area or any other competitors across 12 key performance metrics.

the british institute for the study of iraq (gertrude bell memorial) Ownership

THE BRITISH INSTITUTE FOR THE STUDY OF IRAQ (GERTRUDE BELL MEMORIAL) group structure

The British Institute For The Study Of Iraq (Gertrude Bell Memorial) has no subsidiary companies.

Ultimate parent company

THE BRITISH INSTITUTE FOR THE STUDY OF IRAQ (GERTRUDE BELL MEMORIAL)

06966984

THE BRITISH INSTITUTE FOR THE STUDY OF IRAQ (GERTRUDE BELL MEMORIAL) Shareholders

--

the british institute for the study of iraq (gertrude bell memorial) directors

The British Institute For The Study Of Iraq (Gertrude Bell Memorial) currently has 14 directors. The longest serving directors include Dr John Curtis (Feb 2012) and Dr Gareth Brereton (Feb 2015).

officercountryagestartendrole
Dr John CurtisEngland78 years Feb 2012- Director
Dr Gareth Brereton42 years Feb 2015- Director
Dr Paul Collins61 years Feb 2016- Director
Dr Erica Hunter74 years Feb 2018- Director
Dr Timothy ClaydenUnited Kingdom65 years Feb 2018- Director
Mr Francis BakerEngland64 years Feb 2018- Director
Dr Renad MansourEngland37 years Feb 2020- Director
Dr Rosalind Haddon76 years Feb 2020- Director
Dr Noorah Al-Gailani58 years Feb 2021- Director
Dr Eva Miller36 years Feb 2021- Director

P&L

March 2024

turnover

164.4k

-6%

operating profit

3.3k

0%

gross margin

72.5%

-0.9%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

March 2024

net assets

2.5m

0%

total assets

2.6m

-0.01%

cash

96.3k

+0.01%

net assets

Total assets minus all liabilities

the british institute for the study of iraq (gertrude bell memorial) company details

company number

06966984

Type

Private Limited by guarantee without Share Capital Exempt from using Limited

industry

94990 - Activities of other membership organisations n.e.c.

85590 - Other education n.e.c.

incorporation date

July 2009

age

16

incorporated

UK

ultimate parent company

None

accounts

Total Exemption Full

last accounts submitted

March 2024

previous names

N/A

accountant

ELIZABETH WICKS

auditor

-

address

10 carlton house terrace, london, SW1Y 5AH

Bank

BARCLAYS BANK PLC

Legal Advisor

JACOBS ALLEN HAMMOND

the british institute for the study of iraq (gertrude bell memorial) Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to the british institute for the study of iraq (gertrude bell memorial).

the british institute for the study of iraq (gertrude bell memorial) Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for THE BRITISH INSTITUTE FOR THE STUDY OF IRAQ (GERTRUDE BELL MEMORIAL). This can take several minutes, an email will notify you when this has completed.

the british institute for the study of iraq (gertrude bell memorial) Companies House Filings - See Documents

datedescriptionview/download